Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.

MLA

Chen, Mingyu, et al. “Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.” Liver Cancer (2235-1795), vol. 10, no. 1, Jan. 2021, pp. 38–51. EBSCOhost, https://doi.org/10.1159/000512028.

APA

Chen, M., Cao, J., Hu, J., Topatana, W., Li, S., Juengpanich, S., Lin, J., Tong, C., Shen, J., Zhang, B., Wu, J., Pocha, C., Kudo, M., Amedei, A., Trevisani, F., Sung, P. S., Zaydfudim, V. M., Kanda, T., & Cai, X. (2021). Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma. Liver Cancer (2235-1795), 10(1), 38–51. https://doi.org/10.1159/000512028

Chicago

Chen, Mingyu, Jiasheng Cao, Jiahao Hu, Win Topatana, Shijie Li, Sarun Juengpanich, Jian Lin, et al. 2021. “Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.” Liver Cancer (2235-1795) 10 (1): 38–51. doi:10.1159/000512028.